Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis

por Boher, J-M, Pujol, J-L, Grenier, J, Daurès, J-P
Publicado 1999

Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancer

por Jacot, W, Pujol, J-L, Boher, J-M, Lamy, P-J
Publicado 2004

Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors

por Jacot, W, Quantin, X, Boher, J-M, Andre, F, Moreau, L, Gainet, M, Depierre, A, Quoix, E, Chevalier, T Le, Pujol, J-L
Publicado 2001

Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers.

por Pujol, J. L., Simony, J., Jolimoy, G., Jaffuel, D., Demoly, P., Quantin, X., Marty-Ané, C., Boher, J. M., Charpentier, R., Michel, F. B.
Publicado 1996

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospect...

por Rahal, S., Boher, J M, Extra, J M, Tarpin, C., Charafe-Jauffret, E., Lambaudie, E., Sabatier, R., Thomassin-Piana, J., Tallet, A., Resbeut, M., Houvenaeghel, G., Laborde, L., Bertucci, F., Viens, P., Gonçalves, A.
Publicado 2015